Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPATHY trial of ensovibep in ambulatory adults with symptomatic COVID-19
PACTR202107832151388Phase 2Unknown
- Sponsor
- Molecular Partners AG
- Start
- Apr 2021
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ensovibep with Placebo (2 arms). Status: unknown.
02
Drugs
ensovibep
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202107832151388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202107832151388.